EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Defining RNA oligonucleotides that reverse deleterious phase transitions of RNA-binding proteins with prion-like domains

Lin Guo, Jacob R Mann, Jocelyn C Mauna, Katie E Copley, Hejia Wang, Jack D Rubien, Cristian A Bergmann, Jenny L Carey, Jessica Merjane, Marilyn Ngo, Jiazhen Xu, Hana M Odeh und 21 weitere

Molecular Cell · 2026-01 · 86 (1) · 114-134.e10

DOI: 10.1016/j.molcel.2025.12.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2026-01. Verfasst von Lin Guo und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Biochemistry…. Hauptthemen laut MEDLINE: RNA-Binding Protein FUS, Amyotrophic Lateral Sclerosis, DNA-Binding Proteins, Prions. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NIGMS NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA-binding proteins (RBPs) with prion-like domains (PrLDs), such as FUS and TDP-43, condense into functional liquids, which can transform into pathological fibrils that underpin fatal neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS)/frontotemporal dementia (FTD). Here, we define short RNAs that prevent FUS fibrillization by promoting liquid phases and distinct short RNAs that prevent and reverse FUS condensation and fibrillization. These activities require interactions with multiple RNA-binding domains of FUS and are encoded by RNA sequence, length, and structure. We define a short RNA that dissolves cytoplasmic FUS aggregates, restores nuclear FUS, and mitigates FUS toxicity in optogenetic models and ALS patient-derived motor neurons. Another short RNA dissolves cytoplasmic TDP-43 aggregates, restores nuclear TDP-43, and mitigates TDP-43 toxicity. Since short RNAs can be effectively delivered to the human brain, these oligonucleotides could have utility for ALS/FTD and related disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA-Binding Protein FUSAmyotrophic Lateral SclerosisDNA-Binding ProteinsPrionsRNAFrontotemporal DementiaOligonucleotidesHumansAnimalsMotor NeuronsPhase TransitionProtein DomainsRNA-Binding ProteinsProtein Aggregates

Stichwörter der Autor:innen

ALSFTDFUSRNATDP-43disaggregasephase separationprion-like domain

Substanzen

RNA-Binding Protein FUSDNA-Binding ProteinsTARDBP protein, humanFUS protein, humanPrionsRNAOligonucleotidesRNA-Binding ProteinsProtein Aggregates

Autor:innen und Institutionen

  • Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA,…
  • Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Live Like Lou Center for ALS Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Center for Neuroscie…
  • Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, USA.
  • Department of Biophysics, Johns Hopkins University, Baltimore, MD, USA.
  • Department of Molecular Biology, Cell Biology, and Biochemistry, Brown University, Providence, RI, USA.

Förderung

  • NINDS NIH HHS
  • NIGMS NIH HHS
  • NIA NIH HHS
  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences
  • NIA
  • Office of the Assistant Secretary for Health
  • Alzheimer's Drug Discovery Foundation

Zitieren

APA

Guo, L., Mann, J. R., Mauna, J. C., Copley, K. E., Wang, H., Rubien, J. D., Bergmann, C. A., Carey, J. L., Merjane, J., Ngo, M., Xu, J., Odeh, H. M., Lin, J., Lee, B. L., Ganser, L., Robinson, E., Kim, K. M., Murthy, A. C., Paul, T., …, & Shorter, J. (2026). Defining RNA oligonucleotides that reverse deleterious phase transitions of RNA-binding proteins with prion-like domains. Molecular Cell, 86(1), 114-134.e10. https://doi.org/10.1016/j.molcel.2025.12.009

Vancouver

Guo L, Mann JR, Mauna JC, Copley KE, Wang H, Rubien JD, et al. Defining RNA oligonucleotides that reverse deleterious phase transitions of RNA-binding proteins with prion-like domains. Molecular Cell. 2026;86(1):114-134.e10. doi:10.1016/j.molcel.2025.12.009

BibTeX
@article{Guo2026,
  author = {Guo, Lin and Mann, Jacob R and Mauna, Jocelyn C and Copley, Katie E and Wang, Hejia and Rubien, Jack D and Bergmann, Cristian A and Carey, Jenny L and Merjane, Jessica and Ngo, Marilyn and Xu, Jiazhen and Odeh, Hana M and Lin, JiaBei and Lee, Bo Lim and Ganser, Laura and Robinson, Emma and Kim, Kevin M and Murthy, Anastasia C and Paul, Tapas and Portz, Bede and Gleixner, Amanda M and Diaz, Zamia and Smirnov, Ashleigh and Padilla, George and Lavorando, Ellen and Espy, Carolann and Shang, Yulei and Huang, Eric J and Chesi, Alessandra and Fawzi, Nicolas L and Myong, Sua and Donnelly, Christopher J and Shorter, James},
  title = {Defining RNA oligonucleotides that reverse deleterious phase transitions of RNA-binding proteins with prion-like domains},
  journal = {Molecular Cell},
  year = {2026},
  volume = {86},
  number = {1},
  pages = {114--134.e10},
  doi = {10.1016/j.molcel.2025.12.009}
}
Kostenlos starten →